Table 6.

Performance of (1,3)-β-D-glucan assay for Pneumocystis pneumonia diagnosis in overall non-HIV-infected immunocompromised population and in population of patients with hematological malignancy.

	Overall population	HM-population
Sensitivity (95% CI)	87% (73–94)	64% (35–85)
Specificity (95% CI)	97% (87–99)	100% (74–100)
Positive predictive value (95% CI)	97% (85–99)	100% (64–100)
Negative predictive value (95% CI)	88% (75–95)	73% (48–89)

Performance was determined using the manufacturer’s threshold (80 pg/ml). CI, confidence interval; HM, hematological malignancy.